Hana Pharm Co., Ltd. (KRX: 293480)

South Korea flag South Korea · Delayed Price · Currency is KRW
10,770
-40 (-0.37%)
Nov 15, 2024, 3:30 PM KST
-21.10%
Market Cap 191.59B
Revenue (ttm) 139.33B
Net Income (ttm) 24.30B
Shares Out 17.77M
EPS (ttm) 2,243.00
PE Ratio 4.81
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 23,473
Open 10,800
Previous Close 10,810
Day's Range 10,660 - 10,810
52-Week Range 10,620 - 14,940
Beta 0.47
Analysts n/a
Price Target n/a
Earnings Date Nov 14, 2024

About Hana Pharm

Hana Pharm Co., Ltd. develops and provides various pharmaceutical products in South Korea and internationally. It offers anesthetics, narcotic analgesics, antiemetics, muscle relaxants, cardiovascular and endocrine system, gastrointestinal system, respiratory system, antibiotics, dermatology, urinology, osteoporosis, and central nervous system products, as well as analgesics, antipyretics, and anti-inflammatory drugs. The company was founded in 1996 and is headquartered in Seoul, South Korea. [Read more]

Sector Healthcare
Founded 1996
Country South Korea
Stock Exchange Korea Stock Exchange
Ticker Symbol 293480
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.